Search Tag: breast screening

IMAGING Management

Self-scheduled-mammograms-a-growing-trend-among-younger-patients

2023 29 Sep

A recent study, published in the Journal of the American College of Radiology, revealed an increasing number of patients are taking the initiative to schedule their own screening mammograms through online portals. Notably, this trend is most prominent among younger patients.   The American College of Radiology advises annual screening mammograms...Read more

Women's Health

New-findings-will-help-personalise-approaches-to-breast-cancer-screening

2023 08 Feb

A recent study published in the Journal of Clinical Oncology revealed that women with cancer in one breast may be at a higher risk of developing cancer in the opposite breast. This is subject to them being carriers of specific genetic changes that predispose them to develop breast cancer.   Using data from 15,104 women researchers found that...Read more

IMAGING Management

Esor-foundation-courses-2023-breast-imaging

2023 26 Apr

Find ESOR on Social media   Read more

Women's Health

Hologic-ranked-1-for-mammography-system-performance-and-customer-satisfaction

2022 01 Dec

Global Leader in Women’s Health Recognized with Three IMV ServiceTrak™ Awards for Mammography During RSNA 2022 Hologic , Inc., an innovative medical technology company primarily focused on improving women’s health, swept the 2022 IMV ServiceTrak™ Awards for Mammography, taking home awards for Best Service, Best Customer Satisfaction and...Read more

Women's Health

Study-finds-women-with-benign-breast-disease-face-long-term-risk-of-breast-cancer

2022 25 Nov

A population-based study, involving 7778,306 women aged 50-69 years, assesses their risk of breast cancer after participating in at least one mammographic screening. Researchers compared the incident rates of women diagnosed with and without benign breast cancer.   Women involved in the study had taken part in a breast screening between 1996 and...Read more

Women's Health

Hologic-to-showcase-portfolio-of-comprehensive-breast-and-skeletal-health-solutions-at-rsna-2022

2022 25 Nov

New Affirm® Contrast Biopsy Technology Included in the Screening, Diagnosis, Treatment and Monitoring Solutions on Display Hologic , will exhibit its extensive portfolio of breast and skeletal health products at the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 27 to Dec.1. Among the...Read more

Women's Health

When-should-women-start-breast-cancer-screening

2022 20 Sep

Although breast cancer screening cannot prevent breast cancer, it remains an important public health intervention. The goal is to detect cancer early so it can be treated more successfully.   Although there remains a huge benefit to screening in reducing breastcancer-related deaths, public health experts also acknowledge there are risks and harmful...Read more

Women's Health

Refining-breast-cancer-screening-to-increase-effectiveness

2022 01 Aug

Cancer is a disease that, if left untreated, can progress and spread rapidly and cause death. Breast cancer has a diverse range of pathological entities and can incorporate indolent to aggressive legions. It can have varying histological patterns, clinical presentations, treatment responses and outcomes. Timely screening is essential, and intervening...Read more

Women's Health

Racial-disparities-in-breast-cancer-1

2022 30 Jun

New findings published in Cancer Epidemiology Biomarkers & Prevent show significant differences in the accuracy of diagnostic mammograms across racial and ethnic groups, with variation observed in several measures of diagnostic performance.  Several studies have already established that racial disparities exist in breast cancer. Multiple socioeconomic...Read more

Women's Health

Nice-endorses-magnetic-marker-liquid-probe-for-breast-cancer-metastasis

2022 19 May

The UK National Institute for Health and Care Excellence (NICE) now endorses the use of Magtrace and Sentimag magnetic marker liquids to locate sentinel lymph nodes in women with breast cancer in a new draft guidance.   Sentinel lymph nodes are the first lymph nodes that a primary tumour can drain. When the tracer is injected into a tumour, tracer...Read more

Women's Health

Ai-catches-what-radiologists-miss-on-breast-screening

2022 16 May

A large German study found that AI can accurately detect and localise breast cancers on screening exams missed by radiologists, which in turn can reduce the frequency of cancers between screenings (usually 24 months).   Many breast cancers are clinically detected due the onset of symptoms during the interval between breasts screenings. Often...Read more

Women's Health

Flatiron-data-supports-using-palbociclib-plus-an-aromatase-inhibitor-for-metastatic-breast-cancer

2022 09 May

This Pfizer-sponsored study used de-identified data derived from the Flatiron Health Analytic Database in a retrospective observational study to demonstrate palbociclib (PAL) combined with an aromatase inhibitor (AI) is an effective first-line therapy for treating metastatic breast cancer.   Hormone receptor-positive/human epidermal growth factor...Read more

Women's Health

How-good-is-the-evidence-informing-breast-cancer-clinical-practice-guidelines

2022 05 May

A study published in Clinical Breast Cancer  revealed that the quality of the systematic reviews that provide the evidence to inform clinical practice guidelines differed widely.   The systematic reviews and meta-analyses used to inform the clinical practice guidelines for the National Comprehensive Cancer Network (U.S.) and European Society...Read more

Women's Health

How-do-perceptions-of-radiologists-and-ai-systems-in-breast-screening-differ

2022 05 May

A study published in Nature Scientific Reports  revealed striking differences in the way radiologists and artificial intelligence (AI) systems perceive breast cancer lesions. Given that how they recognise breast cancer differs, this New York University study demonstrates the potential value of combining both human and AI methods when making medical...Read more

Women's Health

Ascos-clinical-practice-guideline-now-supports-extended-endocrine-therapy-with-breast-cancer-indextm

2022 27 Apr

Hologic, Inc.announced today that the American Society of Clinical Oncology (ASCO) has published an update which expands the utility of Breast Cancer Index™ (BCI) within its Clinical Practice Guideline: “Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer.” Specifically, ASCO now recognizes BCI as the   only genomic   test...Read more

Women's Health

Ai-in-population-breast-screening-cuts-radiologist-workload-by-63

2022 25 Apr

Danish and Dutch researchers recently demonstrated that using artificial intelligence (AI) as an aid in population-based breast screening can cut radiologist workload by 63% and false positive finding by 25%.   Examining the mammograms produced by population-based breast cancer screening program produces a significant workload for radiologists....Read more

Women's Health

Talk-test-treat-stds-are-preventable-treatable-and-mostly-curable

2022 14 Apr

Sexually Transmitted Disease (STD) Awareness Week is observed in the U.S. yearly during the second whole week of April. The U.S. Centers for Disease Control and Prevention (CDC) estimates that 20% of the U.S. (68 million) had a sexually transmitted infection (STI) in 2018. About 26 million were new infections which incurred USD $16 billion in direct...Read more

Women's Health

Ai-as-second-reader-performs-well-in-breast-cancer-screening

2022 31 Mar

Researchers from the Cancer Registry of Norway demonstrated that a commercial artificial intelligence (AI) system could detect breast cancer from mammographic images and serve as a second reader in a retrospective study published in Radiology . Examining mammograms gathered as part of a population-based breast cancer screening program produces...Read more

Women's Health

Her2-positive-breast-cancers-no-longer-brings-a-poor-prognosis

2022 24 Mar

Brazilian researchers (Porto Alegre, RS, Brazil) recently examined whether HER2-positive breast cancers should still be associated with poor prognosis given the advance in HER2-targeted therapies.   HER2, found on the surface of all breast cells, is a protein involved in cell growth. HER2-positive breast cancers are normally aggressive and associated...Read more

Women's Health

An-ai-algorithm-for-determining-breast-density-on-bi-rads-scale

2022 23 Mar

An Italian research group (Milan, Italy) recently described a fully automated artificial intelligence (AI)-system for measuring breast density in Radiology: Artificial Intelligence .   Breast density is a common risk factor for breast cancer because it can reduce the sensitivity of mammography screening. Density is commonly visually rated on the...Read more

Women's Health

Mammograms-shouldnt-revolve-around-covid-19-vaccinations

2022 16 Mar

The Society of Breast Imaging (SBI) now recommends that women should not delay mammograms due to COVID-19 vaccinations. Lymph node swelling caused by vaccination presented a concern for false positives because this is a signal also associated with cancer. Women were advised in 2021 to delay mammograms to avoid false-positive results and unnecessary...Read more

IMAGING Management

Eusobi-recommends-mri-screening-in-women-with-extremely-dense-breasts

2022 08 Mar

The European Society of Breast Imaging released its new recommendations for screening of women with extremely dense breasts. In this recommendation EUSOBI steps away from the one-size-fits all approach of biennial mammography that is currently adopted by most European screening organizations and advocates for tailored screening programs that take the...Read more

Women's Health

Low-breast-cancer-risk-does-not-justify-infrequent-screening

2022 08 Feb

A new study from Australia found that 41% of screen-detected breast cancers occurred in women with no recorded risk factors.   Globally and in Australia, there’s been interest in risk-stratified breast screening to improve benefits while reducing screening-associated harms.Increasing screening frequency or more sensitive imaging would be used for...Read more

Women's Health

Hologic-launches-first-ever-national-advertising-campaign-featuring-mary-j-blige

2022 02 Feb

--Leader in women’s health shines spotlight on preventive screenings in commercial created by women, for women premiering during one of America's biggest events-- Hologic, Inc. an innovative medical technology company primarily focused on improving women’s health, announced the details of its first national, direct-to-consumer advertising campaign....Read more

Women's Health

Digital-breast-tomosynthesis-continues-to-perform-well-after-10-years

2021 14 Dec

Over the last ten years, digital breast tomosynthesis (DBT) has continued to provide better cancer detection with fewer false positives than 2D digital mammography. At RSNA 2021, Dr Liane E Philpotts of Yale School of Medicine presented a study comparing DBT’s performance to 2D mammography over a ten-year period.    An X-ray source travels in...Read more

Women's Health

Women-prefer-false-alarms-over-missed-cancers-in-breast-cancer-screening

2021 14 Dec

A large German study found that most women who participate in breast cancer screening prefer a reliable cancer diagnosis over avoiding false-positive findings. Dr Toni Vomweg, a radiologist at  Radiologisches Institut  in Koblenz, Germany, presented the research findings at RSNA 2021.   Mammography is the current standard of care for breast cancer...Read more

Women's Health

Rsna2021-hologic-to-host-innovative-product-experiences-and-information-sessions-1

2021 22 Nov

Hologic  will showcase its extensive portfolio of breast and skeletal health products, including screening and diagnostics solutions, breast biopsy, and breast cancer treatment and monitoring solutions, at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 28 to Dec. 2. On-site at McCormick...Read more

Executive Health Management

Cervical-cancer-cut-by-87-in-hpv-vaccinated-women

2021 05 Nov

New research, funded by Cancer Research UK and published in The Lancet, found 87% lower cervical cancer rates in English women who were offered the Cervarix human papillomavirus (HPV) vaccine vaccinated at ages 12 and 13 than unvaccinated women of similar age. This study provides the first direct evidence of Cervarix‘s effectiveness in lowering cervical...Read more

Women's Health

60-of-u-s-women-during-and-after-pregnancy-find-healthcare-unaffordable

2021 01 Nov

University of Michigan researchers in Ann Arbor examined financial hardship among U.S. women during and after pregnancy, which included the prevalence of cost-related unmet healthcare needs, unaffordable healthcare, and general financial stress.   The study examined financial hardship in 3509 peripartum women, aged 18 to 45 years, who participated...Read more

Women's Health

The-lasting-impact-of-the-covid-19-pandemic-on-breast-cancer-screening

2021 18 Aug

The ongoing coronavirus pandemic has taken a tremendous toll on global humanity, upending life as we know it and resulting in millions of lives lost across the world. In order to handle and best serve the constant influx of COVID-19 patients, health care facilities all over Europe have had to make sacrifices and reallocate resources, leading to delays and...Read more